Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lipoic acid decreases breast cancer cell proliferation by inhibiting IGF-1R via furin downregulation. | Br J Cancer | 2020 | 31988347 | PubTator, text mining | PubMed |
| Dstyk mutation leads to congenital scoliosis-like vertebral malformations in zebrafish via dysregulated mTORC1/TFEB pathway. | Nat Commun | 2020 | 31980602 | PubTator, text mining | PubMed |
| Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers. | Cancer Cell | 2020 | 31978326 | PubTator, text mining | PubMed |
| Effects of the multi-kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia. | J Cell Mol Med | 2020 | 31967735 | PubTator, text mining | PubMed |
| Paracrine senescence of human endometrial mesenchymal stem cells: a role for the insulin-like growth factor binding protein 3. | Aging (Albany NY) | 2020 | 31951594 | PubTator, text mining | PubMed |
| CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γc cytokine stimulation via PI3K/mTOR axis. | Cancer Immunol Immunother | 2020 | 31950225 | PubTator, text mining | PubMed |
| The Communication Between the PI3K/AKT/mTOR Pathway and Y-box Binding Protein-1 in Gynecological Cancer. | Cancers (Basel) | 2020 | 31947591 | PubTator, text mining | PubMed |
| Histologic features of graft-versus-host disease-associated angiomatosis: Insights into pathophysiology and treatment. | J Am Acad Dermatol | 2020 | 31923444 | PubTator, text mining | PubMed |
| YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling. | J Cancer Res Clin Oncol | 2020 | 31912229 | PubTator, text mining | PubMed |
| Everolimus Inhibits the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer Via Downregulation of MMP9 Expression. | Clin Cancer Res | 2020 | 31871301 | PubTator, text mining | PubMed |
| Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations. | Neuropathol Appl Neurobiol | 2020 | 31869431 | PubTator, text mining | PubMed |
| Discovery of an AKT Degrader with Prolonged Inhibition of Downstream Signaling. | Cell Chem Biol | 2020 | 31859249 | PubTator, text mining | PubMed |
| Cyclin-dependent kinase 4 inhibits the translational repressor 4E-BP1 to promote cap-dependent translation during mitosis-G1 transition. | FEBS Lett | 2020 | 31853978 | PubTator, text mining | PubMed |
| A Proteomic Connectivity Map for Characterizing the Tumor Adaptive Response to Small Molecule Chemical Perturbagens. | ACS Chem Biol | 2020 | 31846293 | PubTator, text mining | PubMed |
| Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT). | Clin Cancer Res | 2020 | 31836609 | PubTator, text mining | PubMed |
| The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas. | Brain | 2020 | 31834371 | PubTator, text mining | PubMed |
| A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index. | Cancer Prev Res (Phila) | 2020 | 31818851 | PubTator, text mining | PubMed |
| Cooperative Blockade of PKCα and JAK2 Drives Apoptosis in Glioblastoma. | Cancer Res | 2020 | 31806641 | PubTator, text mining | PubMed |
| Manganese Acts upon Insulin/IGF Receptors to Phosphorylate AKT and Increase Glucose Uptake in Huntington's Disease Cells. | Mol Neurobiol | 2020 | 31797328 | PubTator, text mining | PubMed |
| Therapeutic Enhancement of Verteporfin-mediated Photodynamic Therapy by mTOR Inhibitors. | Photochem Photobiol | 2020 | 31769520 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=49